Androgenic Alopecia, Telogen Effluviam & Postpartun Hair Loss

‍

Androgenic Alopecia, or male and female pattern hair loss, is a common type of genetic hair loss affecting both men and women. It is the most common cause of balding and can be found in up to 90% of cases. Androgenic Alopecia is caused by a hormone imbalance where testosterone converts into dihydrotestosterone (DHT) which shrinks the affected follicles causing them to stop producing new hairs. This type of hair loss targets specific areas on the scalp causing thinning or bald spots in these places rather than being an overall thinning process.

Telogen Effluviam hair loss is another common type of hair loss with varying causes such as stress, diet, poor nutrition, illness and hormonal changes. This type of hair loss isn't genetics but rather the result of a temporary shock to the follicles. In cases of Telogen Effluviam, the scalp sheds more hairs than would normally be shed in any given cycle causing noticeable thinning or balding. This type of hair loss is typically temporary and can usually resolve itself within 6 months with proper treatment.

Post-partum hair loss is caused by fluctuating hormones as a woman's body returns to its pre-pregnancy state. During pregnancy, some women experience thicker, healthier looking locks due to increased estrogen levels that promote healthy hair growth during this period. After giving birth however, those hormones drop quickly resulting in shedding and thinning of the hair. Post-partum hair loss can last anywhere from three to six months and is usually not permanent, although in some cases it can take up to one year for the scalp to return to its pre-pregnancy state.

Platelet Rich Plasma (PRP) therapy has been found to be an effective treatment option for Androgenic Alopecia. PRP involves taking a sample of your own blood and putting it through a process that separates out the platelets which are then re-injected back into the scalp along with other healing agents. The activated platelets release growth factors that promote healthy new cell growth, helping restore the follicles weakened by DHT and encouraging them to begin producing new hairs again.

Alma TED ultrasound therapy is also used to treat Androgenic Alopecia and other types of hair loss. This non-invasive treatment stimulates the scalp with low-frequency sound waves, which helps nourish and protect the follicles from further damage caused by DHT. It has been found to help activate dormant follicles and increase blood circulation to the scalp, both of which are important for healthy hair growth. It can be used on its own or combined with PRP therapy for optimal results in treating genetic hair loss conditions such as Androgenic Alopecia.

In conclusion, Androgenic Alopecia, Telogen Effluviam & Postpartum Hair Loss are all common types of hair loss that affect both men and women. While Androgenic Alopecia is caused by a hormone imbalance, Telogen Effluviam & Postpartum Hair Loss can be triggered by a variety of health conditions or lifestyle factors. Platelet Rich Plasma (PRP) therapy and Alma TED ultrasound therapy are two effective treatment options for restoring healthy hair growth in those who suffer from any type of genetic hair loss condition.